P261-401: A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intranasal Midazolam in the Outpatient Treatment of Subjects with Seizure Clusters

Grants and Contracts Details

StatusFinished
Effective start/end date4/1/143/31/17

Funding

  • inVentiv Health Clinical: $10,737.00